Curis, Inc. (CRIS)
NASDAQ: CRIS · IEX Real-Time Price · USD
6.49
-0.18 (-2.70%)
At close: Jul 19, 2024, 4:00 PM
6.58
+0.09 (1.39%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Curis Revenue
Curis had revenue of $9.81M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $2.09M. In the year 2023, Curis had annual revenue of $10.02M.
Revenue (ttm)
$9.81M
Revenue Growth
-5.67%
P/S Ratio
3.90
Revenue / Employee
$200,245
Employees
49
Market Cap
38.25M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 10.02M | -139.00K | -1.37% |
Dec 31, 2022 | 10.16M | -487.00K | -4.57% |
Dec 31, 2021 | 10.65M | -186.00K | -1.72% |
Dec 31, 2020 | 10.84M | 831.00K | 8.31% |
Dec 31, 2019 | 10.00M | -424.00K | -4.07% |
Dec 31, 2018 | 10.43M | 530.00K | 5.35% |
Dec 31, 2017 | 9.90M | 2.37M | 31.50% |
Dec 31, 2016 | 7.53M | -351.00K | -4.46% |
Dec 31, 2015 | 7.88M | -1.97M | -19.96% |
Dec 31, 2014 | 9.84M | -5.16M | -34.39% |
Dec 31, 2013 | 15.00M | -1.97M | -11.61% |
Dec 31, 2012 | 16.97M | 2.21M | 14.97% |
Dec 31, 2011 | 14.76M | -1.24M | -7.73% |
Dec 31, 2010 | 16.00M | 7.41M | 86.26% |
Dec 31, 2009 | 8.59M | 223.32K | 2.67% |
Dec 31, 2008 | 8.37M | -8.02M | -48.95% |
Dec 31, 2007 | 16.39M | 1.45M | 9.73% |
Dec 31, 2006 | 14.94M | 8.93M | 148.83% |
Dec 31, 2005 | 6.00M | 2.30M | 62.27% |
Dec 31, 2004 | 3.70M | -6.68M | -64.36% |
Dec 31, 2003 | 10.38M | -8.01M | -43.57% |
Dec 31, 2002 | 18.39M | 17.30M | 1,592.64% |
Dec 31, 2001 | 1.09M | 62.93K | 6.15% |
Dec 31, 2000 | 1.02M | -2.19M | -68.13% |
Dec 31, 1999 | 3.21M | -7.22M | -69.20% |
Dec 31, 1998 | 10.43M | -2.66M | -20.31% |
Dec 31, 1997 | 13.09M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Oncology Institute | 342.71M |
Concord Medical Services Holdings | 75.80M |
electroCore | 18.69M |
Aligos Therapeutics | 13.79M |
Mobile-health Network Solutions | 7.87M |
Cue Biopharma | 7.02M |
CRIS News
- 12 days ago - Curis to Present at Upcoming Healthcare Conference in July - PRNewsWire
- 14 days ago - Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 2 months ago - Curis Announces Additional Data from TakeAim Leukemia Study - PRNewsWire
- 2 months ago - Curis to Present Updated Data from the TakeAim Leukemia Study - PRNewsWire
- 2 months ago - Curis Provides First Quarter 2024 Business Update - PRNewsWire
- 2 months ago - Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024 - PRNewsWire
- 3 months ago - Curis to Present at Upcoming Healthcare Conferences in April - PRNewsWire
- 3 months ago - SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Curis, Inc. (NASDAQ: CRIS) - PRNewsWire